期刊文献+

MMP-3和TIMP-3在膀胱移行细胞癌中的表达及意义 被引量:1

Expression and significance of MMP-3 and TIMP-3 in transitional cell carcinoma of bladder
原文传递
导出
摘要 目的研究基质金属蛋白酶3(MMP-3)及其抑制物组织基质金属蛋白酶抑制剂3(TIMP-3)在膀胱移行细胞癌中的表达及其临床意义。方法通过免疫组化Elivision法检测48例膀胱移行细胞癌组织及20例正常膀胱组织中的MMP-3和TIMP-3的表达。结果MMP-3和TIMP-3在正常膀胱组织中不表达,随着肿瘤分级和分期的增高,MMP-3表达增高,但差异无统计学意义(P〉0.05)。TIMP-3表达降低,但在肿瘤分级中差异有统计学意义(P〈0.05)。结论MMP-3的高表达,TIMP-3的低表达与膀胱移行细胞癌的恶性程度有关,在膀胱移行细胞癌的发生发展中起重要作用,可作为临床判断膀胱移行细胞癌的恶性程度及预后的重要参考指标。 Objective To study the expressions and significances of matrix metalloproteinases-3 (MMP-3) and tissue-inhibitor of matrix metalloproteinase-3 (TIMP-3) in transitional cell carcinoma of bladder. Methods Im- munohistochemistry was used to detect the expressions of MMP-3 and TIMP-3 in 48 cases of transitional cell carci- noma of bladder and 20 normal bladder tissues. Results MMP-3 and TIMP-3 in normal bladder tissues did not ex- press. The more grading and staging, the more MMP-3 expression, but no statistical significance (P 〉 0.05), by contrast, TIMP-3 expression decreased and has statistically significant in the tumor grading (P 〈 0.05). Conclusions High expression of MMP-3 and low expression of TIMP-3 is related to the malignancy of transitional cell carcinoma of bladder and may play an important role in the development of transitional cell carcinoma of blad- der, as an important reference to judge the degree of malignancy of transitional cell carcinoma of bladder and prognostic indicator.
出处 《国际外科学杂志》 2013年第8期544-546,F0003,共4页 International Journal of Surgery
关键词 膀胱肿瘤 基质金属蛋白酶3 基质金属蛋白酶抑制剂3 免疫化学 Urinary bladder neoplasms Matrix metalloproteinase 3 Tissue inhibitor of metalloproteinase-3 Immunochemistry
  • 相关文献

参考文献14

  • 1Ylisirnio S, Hfiyhtya M, Turpeenniemi-Hujanen T. Serum matrix metalloproteinases-2, -9 and tissue inhibitors of metalloproteinase- 1, -2 in lung cancer TIMP-1 as a prognostic marker[ J ]. Antican- cer Res, 2000, 20(2B) : 1311-1316.
  • 2Newby AC. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotie plaque rupture [ J ]. Physiol Rev, 2005, 85(1) : 1-31.
  • 3Tanaka A, Matsuda H. IgE crosslinkage of Fecpsilon receptor I in- duces both production and activation of matrix metalloproteinase-9 in mastcells [ J ]. Cell Immunol, 2004, 228 ( 1 ) : 66-75.
  • 4Jin X, Yagi M, Akiyama N, et al. Matriptase activates stromelysin (MMP-3) and promotes tumor growth and angiogenesis[ J]. Canc- er Sci, 2006, 97(12) : 1327-1334.
  • 5Johansson N, Ahonen M, Kahari VM. Matrix metalloproteinases in tumor invasion[J]. Cell Mol Life Sci, 2000, 57(1): 5-15.
  • 6Forget MA, Desrosiers RR, B61iveau R. Physiologieal roles of ma- trix metalloproteinases : implications for tumor growth and metastasis [J]. Can J Physiol Pharmacol, 1999, 77(7) : 465-480.
  • 7Sternlieht MD, Bissell MJ, Werb Z. The matrix metalloproteinase stromelysin-1 acts as natural mammary tumor promoter [ J ]. Onco- gene, 2000, 19(8): 1102-1113.
  • 8Zhang M, Dai C, Zhu H, et al. Clophilin A promotes human hepa- tocellular carcinoma cell metastasis via regulation of MMP-3 and MMP9[J]. Mol Cell Biochem, 2011, 357(1/2): 387-395.
  • 9胡小鹏,任亮,尹航,杨晓勇,王玮,刘航,张小东.转录信号传导子与激活子1和基质金属蛋白酶3在肾移植后尿路上皮肿瘤中的基因表达和临床意义[J].中华泌尿外科杂志,2010,31(10):687-690. 被引量:1
  • 10Spurbeck WW, Ng CY, Vanin EF, et al. Retroviral vector-producer cell-mediated in vivo gene transfer of TIMP-3 restricts angiogenesis and neuroblastoma growth in mice [ J]. Cancer Gene Ther, 2003, 10(3) : 161-167.

二级参考文献12

  • 1胡小朋,马麟麟,张小东,王玮,王勇,李晓北,陈晓.肾移植术后并发尿路上皮肿瘤的临床分析[J].中华泌尿外科杂志,2006,27(7):493-495. 被引量:18
  • 2Campistol JM,Eris J,Oberbauer R,et al.Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation.J Am Soc Nephrol,2006,17:581-589.
  • 3Flanagan KH,Brennan DC.EBV-associated recurrent Hodgkin's disease after renal transplantation.Transpl Int,2006,19:338-341.
  • 4Mizoguchi M,Betensky RA,Batchelor TT,et al.Activation of STAT3,MAPK,and AKT in malignant astrocytic gliomas:correlation with EGFR statua,tumor grade,and survival.J Neuropathol Exp Neurol,2006,65:1181-1188.
  • 5Itoh M,Murata T,Suzuki T,et al.Requirement ot STAT3activation for maximal collagenase-1 (MMP-1) induction by epidermal growth factor and malignant characteristics in T24bladder cancer cells.Oncogene,2006,25:1195-1204.
  • 6Labbe E,Lock L,Letamendia A,et al.Transcriptional cooperation between the transforming growth factor-beta and Wnt pathways in mammary and intestinal tumorigenesis.Cancer Res,2007,67:75-84.
  • 7Balasubramanian L,Evens AM.Targeting angiogenesis for the treatment of sarcoma.Curr Opin Oncol,2006,18:354-359.
  • 8Klein G,Imreh S,Zabarovsky ER.Why do we not all die of cancer at an early age? Adv Cancer Res,2007,98:1-16.
  • 9Khodarev NN,Minn AJ,Efimova EV,et al.Signal transducer and activator of transcription 1 regulates both cytotoxic and prosurvival functions in tumor cells.Cancer Res,2007,67:9214-9220.
  • 10Gao C,Mi Z,Guo H,et al.Osteopontin regulates ubiquitindependent degradation of Statl in murine mammary epithelial tumor cells.Neoplasia,2007,9:699-706.

同被引文献1

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部